ARCHIVES

Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed

This article is from The Cancer Letter archive.

Vol. 05 No. 49 | December 7, 1979

Download PDF Visit The Full Archive

Related Articles

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978

FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots

October 14, 1988

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986